Cure My Disease

Don't miss your cure!

 Log in / Sign up

Argon plasma zaps stomach bugs in new trial

NCT ID NCT06529159

Recruiting now Disease control Sponsor: Christopher C. Thompson, MD, MSc Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new way to treat H. pylori, a bacteria that can cause stomach ulcers and cancer. During an endoscopy, doctors fill the stomach with a saltwater solution that is activated by argon plasma to kill the bacteria. The trial will compare two methods of making this solution and check if it reduces H. pylori levels. Twenty adults with untreated H. pylori will take part, and all will still receive standard antibiotics after the procedure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
argon plasma activated saline solution
What this could lead to
If successful, this could offer a new, non-antibiotic way to reduce H. pylori bacteria during an endoscopy, potentially improving treatment outcomes.
What could go wrong
This is a very early pilot study with only 20 people. It is testing a new procedure, so safety and effectiveness are not yet proven. Participants still need standard antibiotics afterward.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for H. PYLORI GASTROINTESTINAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Helicobacter pylori infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

H. PYLORI GASTROINTESTINAL DISEASE H.PYLORI INFECTION HELICOBACTER PYLORI HELICOBACTER PYLORI GASTROINTESTINAL TRACT INFECTION HELICOBACTER PYLORI INFECTION

Contacts and locations

Locations

  • Brigham and Women's Hospital

    RECRUITING

    Boston, Massachusetts, 02115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.